Why Labcorp Holdings Stock Dropped Today

LH stock dropped 3.3% after the Centers for Medicare & Medicaid Services announced plans to cut laboratory testing reimbursement rates by 15% starting next year, with potential additional reductions extending through 2029.

CMS represents approximately 8% of Labcorp's total revenue. A full 15% reimbursement cut would reduce the company's annual revenue by 1.2%. If the cuts continue through 2029 as outlined in the CMS plan, the worst-case scenario would see revenue decline by 3.6%.

The immediate selloff suggests the market priced in the extended cut scenario rather than just the initial 15% reduction. Medicare and Medicaid reimbursement changes directly impact diagnostic testing margins, and the multi-year structure of the announced cuts creates sustained earnings headwinds for laboratory operators.

The proposed cuts reflect broader federal efforts to reduce healthcare spending, particularly in the diagnostic testing category where reimbursement rates have faced downward pressure in recent years.